Home › Companies › KRYSTAL BIOTECH INC. › 2023-2024
Compiled from SEC Form N-PX filings and KRYSTAL BIOTECH INC.’s Form 8-K, filed 2024-05-21 (Item 5.07 on EDGAR). Page generated 02 October 2026.
Explore KRYSTAL BIOTECH INC. in the interactive database Compare manager voting policies
These tallies are KRYSTAL BIOTECH INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2024-05-21 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Outcome |
|---|---|---|---|---|---|---|
| Elect Director: Suma M. Krishnan | 21,058,004 | -- | -- | 1,498,017 | 2,244,047 | Majority: yes |
| Elect Director: Julian S. Gangolli | 17,226,067 | -- | -- | 5,329,954 | 2,244,047 | Majority: yes |
| Elect Director: Catherine Mazzacco | 20,382,924 | -- | -- | 2,173,097 | 2,244,047 | Majority: yes |
| Proposal Two: Ratification of Appointment of Independent Registered Public Accounting Firm The Company's stockholders ratified the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year en | 24,769,838 | 7,438 | 22,792 | -- | -- | Majority: yes |
| Proposal Three: Non-Binding, Advisory Vote on Named Executive Officer Compensation The Company's stockholders approved, on an advisory (non-binding) basis, the compensation of the Company's named executive officers for the fiscal year ended | 21,697,311 | 851,690 | 7,020 | -- | 2,244,047 | Majority: yes |
Source: KRYSTAL BIOTECH INC., Form 8-K, filed with the SEC on 2024-05-21 — read the filing on EDGAR.
Each item below shows how the 254 asset managers that disclosed a KRYSTAL BIOTECH INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of KRYSTAL BIOTECH INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 16 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
KRYSTAL BIOTECH INC.’s own tally for this item (“Proposal Three: Non-Binding, Advisory Vote on Named Executive Officer Compensation The Company's stockholders approved, on an advisory (non-binding) basis, the compensation of the Company's named executive officers for t”): 21,697,311 for, 851,690 against, per its Form 8-K filed 2024-05-21 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 28,528,000 outstanding shares: 76% for, 3% against (79% of the company cast a for/against vote).
The 254 asset managers below cast 96% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the total votes cast at the meeting.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 7,857,314 | 0 | 0 | 0 | For |
| Vanguard | 2,431,223 | 0 | 0 | 0 | For |
| Redmile Group, LLC | 1,508,250 | 0 | 0 | 0 | For |
| State Street | 1,348,870 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,187,591 | 0 | 0 | 0 | For |
| BlackRock | 1,035,083 | 0 | 0 | 0 | For |
| JENNISON ASSOCIATES LLC | 587,696 | 1,364 | 0 | 0 | For |
| Dimensional | 522,967 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 497,283 | 0 | 0 | 0 | For |
| Hood River Capital Management LLC | 463,142 | 0 | 0 | 0 | For |
| LORD, ABBETT & CO. LLC | 425,363 | 0 | 0 | 0 | For |
| Nuveen | 381,101 | 0 | 0 | 0 | For |
| Charles Schwab | 377,578 | 0 | 0 | 0 | For |
| Lord Abbett | 347,342 | 0 | 0 | 0 | For |
| Prudential/PGIM | 346,253 | 0 | 0 | 0 | For |
| UBS | 0 | 265,652 | 0 | 0 | Against |
| Woodline Partners LP | 252,526 | 0 | 0 | 0 | For |
| Victory Capital | 246,397 | 0 | 0 | 0 | For |
| Manager Directed Portfolios | 246,194 | 0 | 0 | 0 | For |
| SEB Investment Management AB | 0 | 244,061 | 0 | 0 | Against |
| TIAA | 242,516 | 0 | 0 | 0 | For |
| Northern Trust | 193,872 | 15 | 0 | 0 | For |
| JPMorgan | 177,036 | 0 | 0 | 0 | For |
| Man Group plc | 0 | 157,550 | 0 | 0 | Against |
| MUTUAL FUND SERIES TRUST | 136,485 | 0 | 0 | 0 | For |
Showing the 25 largest of 254 asset managers. See all 254 in the interactive database.
Combines 5 wordings of this item as funds reported it.
99.9% Majority: yes · of votes cast
KRYSTAL BIOTECH INC.’s own tally for this item (“Proposal Two: Ratification of Appointment of Independent Registered Public Accounting Firm The Company's stockholders ratified the appointment of KPMG LLP as the Company's independent registered public accounting firm fo”): 24,769,838 for, 7,438 against, per its Form 8-K filed 2024-05-21 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 28,528,000 outstanding shares: 87% for, 0.1% against (87% of the company cast a for/against vote).
The 87 asset managers below cast 99.9% of the shares they voted on this item FOR (10,662,371 for, 81 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 3,613,988 | 0 | 0 | 0 | For |
| Vanguard | 2,370,200 | 0 | 0 | 0 | For |
| T. Rowe Price | 531,854 | 0 | 0 | 0 | For |
| BlackRock | 496,028 | 0 | 0 | 0 | For |
| Dimensional | 468,691 | 0 | 0 | 0 | For |
| State Street | 462,711 | 0 | 0 | 0 | For |
| Lord Abbett | 347,342 | 0 | 0 | 0 | For |
| Prudential/PGIM | 344,687 | 0 | 0 | 0 | For |
| Manager Directed Portfolios | 246,194 | 0 | 0 | 0 | For |
| TIAA | 242,516 | 0 | 0 | 0 | For |
| Charles Schwab | 188,778 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 136,485 | 0 | 0 | 0 | For |
| Victory Capital | 88,375 | 0 | 0 | 0 | For |
| TimesSquare Capital Management, LLC | 84,841 | 0 | 0 | 0 | For |
| Equitable | 71,030 | 0 | 0 | 0 | For |
| Goldman Sachs | 67,089 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 60,000 | 0 | 0 | 0 | For |
| Nuveen | 56,523 | 0 | 0 | 0 | For |
| Putnam | 51,045 | 0 | 0 | 0 | For |
| John Hancock | 44,314 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 43,692 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 43,054 | 0 | 0 | 0 | For |
| Jackson National | 40,316 | 0 | 0 | 0 | For |
| Allspring | 39,102 | 0 | 0 | 0 | For |
| Aberdeen | 39,024 | 0 | 0 | 0 | For |
Showing the 25 largest of 87 asset managers. See all 87 in the interactive database.
Combines 5 wordings of this item as funds reported it.
90% Majority: yes · of votes cast
KRYSTAL BIOTECH INC.’s own tally for this item (“Elect Director: Catherine Mazzacco”): 20,382,924 for, 2,173,097 withheld, per its Form 8-K filed 2024-05-21 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 28,528,000 outstanding shares: 71% for, 8% withheld (79% of the company cast a for/withheld vote).
The 83 asset managers below cast 99.9% of the shares they voted on this item FOR (9,625,171 for, 14 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 3,613,988 | 0 | 0 | 0 | For |
| Vanguard | 2,370,200 | 0 | 0 | 0 | For |
| T. Rowe Price | 531,854 | 0 | 0 | 0 | For |
| BlackRock | 496,028 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 468,691 | 0 | Abstain |
| State Street | 462,085 | 0 | 626 | 0 | For |
| Lord Abbett | 347,342 | 0 | 0 | 0 | For |
| Prudential/PGIM | 342,273 | 0 | 2,414 | 0 | For |
| Manager Directed Portfolios | 246,194 | 0 | 0 | 0 | For |
| TIAA | 242,516 | 0 | 0 | 0 | For |
| Charles Schwab | 188,778 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 136,485 | 0 | 0 | 0 | For |
| Victory Capital | 0 | 0 | 88,375 | 0 | Abstain |
| TimesSquare Capital Management, LLC | 84,841 | 0 | 0 | 0 | For |
| Equitable | 47,770 | 0 | 23,260 | 0 | For |
| Goldman Sachs | 0 | 0 | 67,089 | 0 | Abstain |
| Franklin Custodian Funds | 60,000 | 0 | 0 | 0 | For |
| Nuveen | 56,523 | 0 | 0 | 0 | For |
| Putnam | 51,045 | 0 | 0 | 0 | For |
| John Hancock | 36,281 | 0 | 8,033 | 0 | For |
| Columbia Threadneedle | 43,692 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 3,934 | 0 | 39,120 | 0 | Abstain |
| Jackson National | 0 | 0 | 40,316 | 0 | Abstain |
| Allspring | 0 | 0 | 39,102 | 0 | Abstain |
| Aberdeen | 0 | 0 | 39,024 | 0 | Abstain |
Showing the 25 largest of 83 asset managers. See all 83 in the interactive database.
Combines 5 wordings of this item as funds reported it.
76% Majority: yes · of votes cast
KRYSTAL BIOTECH INC.’s own tally for this item (“Elect Director: Julian S. Gangolli”): 17,226,067 for, 5,329,954 withheld, per its Form 8-K filed 2024-05-21 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 28,528,000 outstanding shares: 60% for, 19% withheld (79% of the company cast a for/withheld vote).
The 83 asset managers below cast 99.9% of the shares they voted on this item FOR (8,907,811 for, 14 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 3,613,988 | 0 | 0 | 0 | For |
| Vanguard | 2,370,200 | 0 | 0 | 0 | For |
| T. Rowe Price | 531,854 | 0 | 0 | 0 | For |
| BlackRock | 496,028 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 468,691 | 0 | Abstain |
| State Street | 460 | 0 | 462,251 | 0 | Abstain |
| Lord Abbett | 347,342 | 0 | 0 | 0 | For |
| Prudential/PGIM | 342,273 | 0 | 2,414 | 0 | For |
| Manager Directed Portfolios | 246,194 | 0 | 0 | 0 | For |
| TIAA | 242,516 | 0 | 0 | 0 | For |
| Charles Schwab | 188,778 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 136,485 | 0 | 0 | 0 | For |
| Victory Capital | 0 | 0 | 88,375 | 0 | Abstain |
| TimesSquare Capital Management, LLC | 84,841 | 0 | 0 | 0 | For |
| Equitable | 47,770 | 0 | 23,260 | 0 | For |
| Goldman Sachs | 0 | 0 | 67,089 | 0 | Abstain |
| Franklin Custodian Funds | 0 | 0 | 60,000 | 0 | Abstain |
| Nuveen | 56,523 | 0 | 0 | 0 | For |
| Putnam | 51,045 | 0 | 0 | 0 | For |
| John Hancock | 36,281 | 0 | 8,033 | 0 | For |
| Columbia Threadneedle | 0 | 0 | 43,692 | 0 | Abstain |
| Bridge Builder Trust | 3,934 | 0 | 39,120 | 0 | Abstain |
| Jackson National | 0 | 0 | 40,316 | 0 | Abstain |
| Allspring | 0 | 0 | 39,102 | 0 | Abstain |
| Aberdeen | 0 | 0 | 39,024 | 0 | Abstain |
Showing the 25 largest of 83 asset managers. See all 83 in the interactive database.
Combines 5 wordings of this item as funds reported it.
93% Majority: yes · of votes cast
KRYSTAL BIOTECH INC.’s own tally for this item (“Elect Director: Suma M. Krishnan”): 21,058,004 for, 1,498,017 withheld, per its Form 8-K filed 2024-05-21 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 28,528,000 outstanding shares: 74% for, 5% withheld (79% of the company cast a for/withheld vote).
The 83 asset managers below cast 100% of the shares they voted on this item FOR (9,672,304 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 3,613,988 | 0 | 0 | 0 | For |
| Vanguard | 2,370,200 | 0 | 0 | 0 | For |
| T. Rowe Price | 531,854 | 0 | 0 | 0 | For |
| BlackRock | 496,028 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 468,691 | 0 | Abstain |
| State Street | 1,033 | 0 | 461,678 | 0 | Abstain |
| Lord Abbett | 347,342 | 0 | 0 | 0 | For |
| Prudential/PGIM | 344,687 | 0 | 0 | 0 | For |
| Manager Directed Portfolios | 246,194 | 0 | 0 | 0 | For |
| TIAA | 242,516 | 0 | 0 | 0 | For |
| Charles Schwab | 188,778 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 136,485 | 0 | 0 | 0 | For |
| Victory Capital | 88,375 | 0 | 0 | 0 | For |
| TimesSquare Capital Management, LLC | 84,841 | 0 | 0 | 0 | For |
| Equitable | 47,770 | 0 | 23,260 | 0 | For |
| Goldman Sachs | 67,089 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 60,000 | 0 | 0 | 0 | For |
| Nuveen | 56,523 | 0 | 0 | 0 | For |
| Putnam | 51,045 | 0 | 0 | 0 | For |
| John Hancock | 44,314 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 43,692 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 43,054 | 0 | 0 | 0 | For |
| Jackson National | 34,141 | 0 | 6,175 | 0 | For |
| Allspring | 39,102 | 0 | 0 | 0 | For |
| Aberdeen | 39,024 | 0 | 0 | 0 | For |
Showing the 25 largest of 83 asset managers. See all 83 in the interactive database.
Combines 2 wordings of this item as funds reported it.
100% fund support · no official result
The 3 asset managers below cast 100% of the shares they voted on this item FOR (1,913 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Jackson Creek Investment Advisors LLC | 906 | 0 | 0 | 0 | For |
| Zacks Trust | 660 | 0 | 0 | 0 | For |
| SARATOGA ADVANTAGE TRUST | 347 | 0 | 0 | 0 | For |
Ranked by the number of KRYSTAL BIOTECH INC. shares each manager voted on the most widely held ballot item of the 2023-2024 meeting, shown as a share of the 28,528,000 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Fidelity | 27.54% |
| 2 | Vanguard | 8.52% |
| 3 | Redmile Group, LLC | 5.29% |
| 4 | State Street | 4.73% |
| 5 | T. Rowe Price | 4.16% |
| 6 | BlackRock | 3.63% |
| 7 | JENNISON ASSOCIATES LLC | 2.06% |
| 8 | Dimensional | 1.83% |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | 1.74% |
| 10 | Hood River Capital Management LLC | 1.62% |
Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).
| Holder | % outstanding | Disclosure |
|---|---|---|
| FMR (Fidelity) | 15.22% | 13F |
| BlackRock | 13.44% | 13F |
| FMR LLC | 11.74% | DEF14A |
| Vanguard Group | 9.79% | 13F |
| Avoro Capital Advisors LLC | 8.99% | DEF14A |
| Krish S. Krishnan | 6.43% | DEF14A |
| Suma M. Krishnan | 6.15% | DEF14A |
| Redmile Group, LLC | 6.08% | DEF14A |
| State Street | 3.31% | 13F |
| T. Rowe Price | 2.31% | 13F |
Percentages above are of 28,528,000 shares outstanding, as reported by KRYSTAL BIOTECH INC. on its Form 10-Q dated 2024-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from KRYSTAL BIOTECH INC.’s 10-Q dated 2024-03-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.
At KRYSTAL BIOTECH INC.'s shareholder meeting held 2024-05-17, in the 2023-2024 proxy season, 254 asset managers reported how they voted in their SEC Form N-PX filings, covering 1,751 separate fund positions. Their filings are grouped here into 6 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — APPROVAL OF THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS, ON A NON-BINDING… — FOR was 96% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: KRYSTAL BIOTECH INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2024-05-21.
KRYSTAL BIOTECH INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.